Jun 27, 2024
Cepheid Receives FDA Authorization with CLIA Waiver for Xpert® HCV
Jun 27, 2024
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
Apr 03, 2024
Cepheid Announces World Health Organization Prequalification of Xpert HIV-1 Qualitative Test
Jan 18, 2024
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert® Xpress MVP
Jul 16, 2020
New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs
Jun 10, 2020
Cepheid Chooses Qualtrics
May 27, 2020
Global Molecular Diagnostics Market Analysis, Trends and Forecasts with Profiles of Leading Players Including Abbott Laboratories, bioMrieux SA, Cepheid, Hologic Inc. and Thermo Fischer Scientific Inc.
Mar 21, 2020
Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test
Oct 02, 2019
Cepheid Receives FDA Clearance for Xpert® BCR-ABL Ultra Test
Oct 01, 2019
Global Molecular Testing Markets for Infectious Diseases, 2019-2024 Featuring Abbott, bioMrieux, Bio-Rad, Cepheid, Meridian, Qiagen, Quidel, Roche
May 29, 2019
Cepheid Receives FDA Clearance for Extragenital Claims for Xpert® CT/NG Test
Apr 15, 2019
Cepheid Announces FleXible Cartridge Program
Dec 20, 2018
Cepheid Receives CE-IVD Clearance for Xpert® HBV Viral Load
Sep 19, 2018
Cepheid Receives CE-IVD clearance for Xpert HCV VL Fingerstick
Jul 26, 2018
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert® Xpress Flu/RSV Test
May 15, 2018
FDA Clears Expanded Claims for 'Superbug' Test
May 02, 2018
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert Xpress Strep A
Feb 20, 2018
New IDSA/SHEA Guidelines Highlight Critical Role of PCR Testing in C. difficile Diagnosis
Jan 09, 2018
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert® Xpress Flu Test
Oct 05, 2017
Cepheid Expands Respiratory Disease Portfolio with Xpert Xpress Strep A